Literature DB >> 22447561

Potential role for magnetoencephalography in distinguishing low- and high-grade gliomas: a preliminary study with histopathological confirmation.

Tony W Wilson1, Elizabeth Heinrichs-Graham, Michele R Aizenberg.   

Abstract

Gliomas are the most common form of tumor in the CNS and are exceptionally heterogeneous. Accurately characterizing gliomas, in terms of grade and type, is essential for predicting the rate of tumor progression. Histopathological grading and analysis based on biopsied tissue remains the gold standard, but non- and semi-invasive neuroimaging also plays a key role. Neuroimaging has been used to guide and optimize biopsies for several decades, but more recently molecular imaging and variants of MRI have shown promise in independently predicting glioma grade. Here we evaluated whether magnetoencephalographic (MEG) measurements of population-level physiology within the glioma space were predictive of the inherent grade of the tissue, based on definitive histopathological analyses. High-density MEG data were recorded from 11 patients who were undergoing functional mapping in preparation for resective surgery. The primary results indicated that glioma grade was positively correlated with the local amplitude of activity within the glioma space in the theta (4-7 Hz), alpha (8-14 Hz), and beta bands (14-30 Hz). Additionally, activity within the glioma was significantly elevated relative to the nonaffected homologue area in the same frequency bands. These results indicate that pathological levels of synchronization exist within the tumor space and that MEG may be a viable tool for noninvasively differentiating gliomas by their grade. Although these results should be considered preliminary and are only correlative in nature, these data suggest that MEG can potentially detect neurophysiological signatures or markers that predict the inherent grade of a glial tumor.

Entities:  

Mesh:

Year:  2012        PMID: 22447561      PMCID: PMC3337311          DOI: 10.1093/neuonc/nos064

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  31 in total

1.  BESA source coherence: a new method to study cortical oscillatory coupling.

Authors:  Karsten Hoechstetter; Harald Bornfleth; Dieter Weckesser; Nicole Ille; Patrick Berg; Michael Scherg
Journal:  Brain Topogr       Date:  2004       Impact factor: 3.020

2.  11C-methionine PET for differential diagnosis of low-grade gliomas.

Authors:  K Herholz; T Hölzer; B Bauer; R Schröder; J Voges; R I Ernestus; G Mendoza; G Weber-Luxenburger; J Löttgen; A Thiel; K Wienhard; W D Heiss
Journal:  Neurology       Date:  1998-05       Impact factor: 9.910

3.  Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.

Authors:  B Kaschten; A Stevenaert; B Sadzot; M Deprez; C Degueldre; G Del Fiore; A Luxen; M Reznik
Journal:  J Nucl Med       Date:  1998-05       Impact factor: 10.057

4.  Advanced tools for digital EEG review: virtual source montages, whole-head mapping, correlation, and phase analysis.

Authors:  Michael Scherg; Nicole Ille; Harald Bornfleth; Patrick Berg
Journal:  J Clin Neurophysiol       Date:  2002-04       Impact factor: 2.177

5.  Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging.

Authors:  Soonmee Cha; Tarik Tihan; Forrest Crawford; Nancy J Fischbein; Susan Chang; Andrew Bollen; Sarah J Nelson; Michael Prados; Mitchel S Berger; William P Dillon
Journal:  AJNR Am J Neuroradiol       Date:  2005-02       Impact factor: 3.825

6.  Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected].

Authors:  Michael H Lev; Yelda Ozsunar; John W Henson; Amjad A Rasheed; Glenn D Barest; Griffith R Harsh; Markus M Fitzek; E Antonio Chiocca; James D Rabinov; Andrew N Csavoy; Bruce R Rosen; Fred H Hochberg; Pamela W Schaefer; R Gilberto Gonzalez
Journal:  AJNR Am J Neuroradiol       Date:  2004-02       Impact factor: 3.825

7.  Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas.

Authors:  T Sugahara; Y Korogi; M Kochi; I Ikushima; T Hirai; T Okuda; Y Shigematsu; L Liang; Y Ge; Y Ushio; M Takahashi
Journal:  AJR Am J Roentgenol       Date:  1998-12       Impact factor: 3.959

8.  Regional glucose metabolism and histopathology of gliomas. A study based on positron emission tomography-guided stereotactic biopsy.

Authors:  S Goldman; M Levivier; B Pirotte; J M Brucher; D Wikler; P Damhaut; E Stanus; J Brotchi; J Hildebrand
Journal:  Cancer       Date:  1996-09-01       Impact factor: 6.860

9.  Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings.

Authors:  H J Aronen; I E Gazit; D N Louis; B R Buchbinder; F S Pardo; R M Weisskoff; G R Harsh; G R Cosgrove; E F Halpern; F H Hochberg
Journal:  Radiology       Date:  1994-04       Impact factor: 11.105

10.  Correlation of glucose consumption and tumor cell density in astrocytomas. A stereotactic PET study.

Authors:  K Herholz; U Pietrzyk; J Voges; R Schröder; M Halber; H Treuer; V Sturm; W D Heiss
Journal:  J Neurosurg       Date:  1993-12       Impact factor: 5.115

View more
  1 in total

1.  Non-invasively measured brain activity and radiological progression in diffuse glioma.

Authors:  T Numan; S D Kulik; B Moraal; J C Reijneveld; C J Stam; P C de Witt Hamer; J Derks; A M E Bruynzeel; M E van Linde; P Wesseling; M C M Kouwenhoven; M Klein; T Würdinger; F Barkhof; J J G Geurts; A Hillebrand; L Douw
Journal:  Sci Rep       Date:  2021-09-23       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.